Acasti Pharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch Acasti Pharma and buy or sell other stocks, ETFs, and their options commission-free!About ACST
Acasti Pharma, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil.
CEOJanelle D'Alvise
CEOJanelle D'Alvise
Employees—
Employees—
HeadquartersLaval, Québec
HeadquartersLaval, Québec
Founded2002
Founded2002
Employees—
Employees—
ACST Key Statistics
Market cap552.64M
Market cap552.64M
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume6.42M
Average volume6.42M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$1.22
52 Week high$1.22
52 Week low$0.171
52 Week low$0.171
Stock Snapshot
With a market cap of 552.64M, Acasti Pharma(ACST) trades at $2.37.
On 2026-07-14, Acasti Pharma(ACST) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Acasti Pharma(ACST) stock has reached 0, versus its average volume of 6.42M.
The stock's 52-week range extends from a low of $0.17 to a high of $1.22.
The stock's 52-week range extends from a low of $0.17 to a high of $1.22.
People also own
Based on the portfolios of people who own ACST. This list is generated using Robinhood data, and it’s not a recommendation.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.